These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1510 related items for PubMed ID: 19948300

  • 1. A review of heart failure management in the elderly population.
    Cheng JW, Nayar M.
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [Abstract] [Full Text] [Related]

  • 2. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure.
    Howard PA, Cheng JW, Crouch MA, Colucci VJ, Kalus JS, Spinler SA, Munger M.
    Ann Pharmacother; 2006 Sep; 40(9):1607-17. PubMed ID: 16896019
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 4. Improving the management of patients after myocardial infarction, from admission to discharge.
    Amin A.
    Clin Ther; 2006 Oct; 28(10):1509-39. PubMed ID: 17157110
    [Abstract] [Full Text] [Related]

  • 5. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM, American Heart Association Council on Clinical Cardiology, Society of Geriatric Cardiology.
    Circulation; 2007 May 15; 115(19):2549-69. PubMed ID: 17502590
    [Abstract] [Full Text] [Related]

  • 6. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR, Krum H.
    Curr Opin Cardiol; 2006 Jul 15; 21(4):393-9. PubMed ID: 16755210
    [Abstract] [Full Text] [Related]

  • 7. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan 15; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Jan 15; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients.
    Aronow WS.
    Heart Dis; 2003 Jan 15; 5(4):279-94. PubMed ID: 12877761
    [Abstract] [Full Text] [Related]

  • 10. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
    Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML, APPROACH Investigators.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1587-92. PubMed ID: 15489090
    [Abstract] [Full Text] [Related]

  • 11. Diastolic heart failure: state of the science on best treatment practices.
    Reddersen LA, Keen C, Nasir L, Berry D.
    J Am Acad Nurse Pract; 2008 Oct 19; 20(10):506-14. PubMed ID: 19128346
    [Abstract] [Full Text] [Related]

  • 12. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, VALIANT Investigators.
    Circulation; 2005 Nov 29; 112(22):3391-9. PubMed ID: 16301343
    [Abstract] [Full Text] [Related]

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 29; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 14. Challenging the dogma of high target doses in the treatment of heart failure: is more always better?
    Follath F.
    Arch Cardiovasc Dis; 2009 Nov 29; 102(11):785-9. PubMed ID: 19944395
    [Abstract] [Full Text] [Related]

  • 15. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP, Newby LK, Armstrong PW, Cannon CP, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM, American Heart Association Council on Clinical Cardiology, Society of Geriatric Cardiology.
    Circulation; 2007 May 15; 115(19):2570-89. PubMed ID: 17502591
    [Abstract] [Full Text] [Related]

  • 16. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
    Fonarow GC, Gheorghiade M, Abraham WT.
    Am J Cardiol; 2004 Nov 01; 94(9):1155-60. PubMed ID: 15518610
    [Abstract] [Full Text] [Related]

  • 17. Advances in the treatment of heart failure with a preserved ejection fraction.
    Das A, Abraham S, Deswal A.
    Curr Opin Cardiol; 2008 May 01; 23(3):233-40. PubMed ID: 18382212
    [Abstract] [Full Text] [Related]

  • 18. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 May 01; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 19. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS, Bredikis A, Habib G, Carabello BA, Ramasubbu K, Bozkurt B.
    Am J Cardiol; 2008 Nov 15; 102(10):1356-60. PubMed ID: 18993155
    [Abstract] [Full Text] [Related]

  • 20. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov 15; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.